Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: A cost-benefit analysis

Clinical Infectious Diseases

Volumn 39, Issue 1, 2004, Pages 20-28

  Purdy, Kenneth W ^a,b   Hay, Joel W ^a,c   Botteman, Marc F ^d   Ward, Joel I ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d ABT ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BORDETELLA PERTUSSIS; CHILD; COST BENEFIT ANALYSIS; DIPHTHERIA; DRUG COST; DRUG USE; HUMAN; IMMUNIZATION; MATHEMATICAL COMPUTING; PERTUSSIS; PRIORITY JOURNAL; TETANUS;

ADOLESCENT; ADULT; BORDETELLA PERTUSSIS; COST-BENEFIT ANALYSIS; HEALTH PRIORITIES; HUMANS; IMMUNIZATION, SECONDARY; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 3042713713     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/421091     Document Type: Article

References (55)

1. Edwards KM, Decker MD, Mortimer EA Jr. Pertussis vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia: W.B. Saunders, 1999:293-344.
2. Fine PE, Clarkson JA. Reflections on the efficacy of pertussis vaccines. Rev Infect Dis 1987; 9:866-83.
3. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10-year community study. BMJ 1988; 296:612-4.
4. Qiushui H, Viljanen MK, Nikkari S, Lyytikainen R, Mertsola J. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J Infect Dis 1994; 170:873-7.
5. Schmitt-Grohé S, Cherry JD, Heininger U, Überall MA, Pineda E, Stehr K. Pertussis in German adults. Clin Infect Dis 1995; 21:860-6.
6. Deville JG, Cherry JD, Christenson PD, et al. Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis 1995; 21:639-42.
7. Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis 1999;28(Suppl 2):S112-7.
8. Birkebæk NH, Kristiansen M, Seefeldt T, et al. Bordetella pertussis and chronic cough in adults. Clin Infect Dis 1999; 29:1239-42.
9. Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 1990; 161:480-6.
10. Deen JL, Mink CM, Cherry JD, et al. Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995; 21:1211-9.
11. Wirsing von König CH, Postels-Multani S, Bock HL, Schmitt HJ. Pertussis in adults: frequency of transmission after household exposure. Lancet 1995; 346:1326-9.
12. Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis 1996; 173:1256-9.
13. Farizo KM, Cochi SL, Zell ER, Brink EW, Wassilak SG, Patriarca PA. Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis 1992; 14:708-19.
14. Marchant CD, Loughlin AM, Lett SM, et al. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. J Infect Dis 1994; 169:1297-305.
15. Güris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28:1230-7.
16. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis 2000; 182:1409-16.
17. Skowronski DM, De Serres G, MacDonald D, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis 2002; 185:1448-53.
18. Pertussis-United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002; 51:73-6.
19. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003; 290:2968-75.
20. Weber DJ, Rutala WA. Pertussis: an underappreciated risk for nosocomial outbreaks. Infect Control Hosp Epidemiol 1998; 19:825-8.
21. Khetsuriani N, Bisgard K, Prevots R, et al. Pertussis outbreak in an elementary school with high vaccination coverage. Pediatr Infect Dis J 2001; 20:1108-12.
22. Baron S, Njamkepo E, Grimprel E, et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J 1998; 17:412-8.
23. Jansen DL, Gray GC, Putnam SD, Lynn F, Meade BD. Evaluation of pertussis in US Marine Corps trainees. Clin Infect Dis 1997; 25: 1099-107.
24. Jackson LA, Cherry JD, Wang SP, Grayston JT. Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin Infect Dis 2000; 31:3-6.
25. Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996; 275:1672-4.
26. Senzilet LD, Halperin SA, Spika JS, et al. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001; 32:1691-7.
27. Keitel WA, Muenz LR, Decker MD, et al. A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization. J Infect Dis 1999; 180:397-403.
28. Ward JI. Acellular pertussis vaccines in adolescents and adults [abstract 1291]. In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2001:520.
29. Strebel P, Nordin J, Edwards K, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 2001; 183:1353-9.
30. Tran Minh NN, He Q, Edelman K, et al. Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents. Pediatrics 1999; 104:e70-6.
31. Rothstein EP, Anderson EL, Decker MD, et al. An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Vaccine 1999; 17:2999-3006.
32. Halperin SA, Smith B, Russell M, et al. Adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. Pediatr Infect Dis J 2000; 19:276-83.
33. Van der Wielen M, van Damme P, Joossens E, François G, Meurice F, Ramalho A. A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults. Vaccine 2000; 18:2075-82.
34. Christie CDC, Garrison KM, Kiely L, Gupta RK, Heubi J, Marchant CD. A trial of acellular pertussis vaccine in hospital workers during the Cincinnati pertussis epidemic of 1993. Clin Infect Dis 2001; 33: 997-1003.
35. Turnbull FM, Heath TC, Jalaludin BB, Burgess MA, Ramalho AC. A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults. Vaccine 2000; 19: 628-36.
36. Tran Minh NN, He Q, Edelman K, et al. Immune responses to pertussis antigens eight years after booster immunization with acellular vaccines in adults. Vaccine 2000; 18:1971-4.
37. Orenstein WA. Pertussis in adults: epidemiology, signs, symptoms, and implications for vaccination. Clin Infect Dis 1999; 28:5147-50.
38. Edwards KM. Is pertussis a frequent cause of cough in adolescents and adults? Should routine pertussis immunization be recommended? Clin Infect Dis 2001; 32:1698-9.
39. Gardner P. Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations. Clin Infect Dis 1999; 28:S131-5.
40. Sutter RW, Cochi SL. Pertussis hospitalizations and mortality in the United States, 1985-1988: evaluation of the completeness of national reporting. JAMA 1992; 267:386-91.
41. Lee LH, Pichichero ME. Costs of illness due to Bordetella pertussis in families. Arch Fam Med 2000; 9:989-96.
42. Iskedjian M, Einarson TR, O'Brien BJ, et al. Economic evaluation of a new acellular vaccine for pertussis in Canada. Pharmacoeconomics 2001; 19:551-63.
43. De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000; 182:174-9.
44. Christie CDC, Glover AM, Willke JM, Marx ML, Reising SF, Hutchinson NM. Containment of pertussis in the regional pediatric hospital during the greater Cincinnati epidemic of 1993. Infect Control Hosp Epidemiol 1995; 16:556-63.
45. Elixhauser A, Halpern M, Schmier J, Luce BR. Health care CBA and CEA from 1991 to 1996: an updated bibliography. Med Care 1998; 36: MS1-9, MS18-147.
46. Klose T. A utility-theoretic model for QALYs and willingness to pay. Health Econ 2003; 12:17-31.
47. US Census Bureau. Quarterly projections of the resident population by age, sex, race, and Hispanic origin: middle series, January 1, 1999 to January 1, 2101. Available at: http://www.census.gov/population/ projections/nation/ detail/q2001_10.a Accessed 2 April 2003.
48. Hay JW, Daum RS. Cost-benefit analysis of Haemophilus influenzae type b prevention: conjugate vaccination at eighteen months of age. Pediatr Infect Dis J 1990; 9:246-52.
49. Murphy KM, Topel RH, eds. Measuring the gains from medical research: an economic approach. Chicago: University of Chicago Press, 2003.
50. US Census Bureau. Table C2: household relationship and living arrangements of children under 18 years by age, sex, race, Hispanic origin, and metropolitan residence: March 2000. Available at: http://www. census.gov/population/socdemo/hh-fam/p20-537/2000/tabC2.pdf. Accessed 8 June 2004.
51. National Center for Health Statistics. Number of cases annually of chronic bronchitis, emphysema, and asthma by selected characteristics (1997). Available at: http://www.cdc.gov/nchs/fastats/pdf/sr10_205 t4.pdf. Accessed 2 April 2003.
52. National Center for Health Statistics. Summary health statistics for US adults: National Health Interview survey, 2001. Available at: http: //www.cdc.gov/nchs/data/series/sr_10/sr10_218.pdf. Accessed 8 June 2004.
53. Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN, Deitchmann D. Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1998; 19:407-63.
54. Cherry JD. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin Infect Dis 1999;28(Suppl 2):S107-11.
55. Mertens PLJM, Stals FS, Schellekens JFP, Houben AW, Huisman J. An epidemic of pertussis among elderly people in a religious institution in the Netherlands. Eur J Clin Microbiol Infect Dis 1999; 18:242-7.